This inventor holds 1 USPTO granted patent. Top assignee: Jiangsu Hansoh Pharmaceutical Group Co., Ltd.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: The Innovations of Ming Chen
Introduction
Ming Chen is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on drug formulations. His expertise and dedication have led to advancements that enhance drug efficacy and stability.
Latest Patents
Ming Chen holds a patent for a crystal form of tenofovir prodrug, which includes a preparation method and a method of use. This patent describes a crystal form of 9-[(R)-2-[[(S)-[[[1-(isopropoxycarbonyl)-1-methyl]ethyl]amino]phenoxyphosphinyl]methoxyl]propyl]adenine fumarate. The crystal form is characterized by an X-ray powder diffraction (XRPD) spectrum with specific diffraction peaks, indicating its unique properties. This innovation boasts high bioavailability, significant efficacy, good stability, high yield, and high purity. It plays a crucial role in the selection and design of drug administration routes and the determination of process parameters in pharmaceutical preparations, thereby improving drug production quality.
Career Highlights
Ming Chen is associated with Jiangsu Hansoh Pharmaceutical Group Co., Ltd., where he continues to push the boundaries of pharmaceutical research and development. His work has not only contributed to the company's portfolio but has also advanced the field of drug formulation.
Collaborations
Ming Chen collaborates with talented individuals such as Chengyao Tian and Mingli Zhao. Their combined efforts in research and development have led to innovative solutions in the pharmaceutical industry.
Conclusion
Ming Chen's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to improving drug formulations. His work continues to influence the industry positively, paving the way for future advancements.